RxDoctor Payments DataLook up a doctor →

KESIMPTA: payments to doctors

Payments that named KESIMPTA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$4.9M
Providers
8,919
Transactions
160,843
Average per transaction
$30

The per-transaction average — $30 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,919 providers the average total is $549, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis$4,708,51196.1%
Novartis Pharma AG$191,4603.9%
← All drugs & devices